Company
YGION Biomedical GmbH
YGION Biomedical GmbH has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| YG-01 Dose Level 1 | Phase 1 | Glioblastoma |
Latest
No recent events.
Follow YGION Biomedical GmbH on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.